25 June 2025 in The Cleft Palate Craniofacial Journal
Objective: To assess the effectiveness of a novel surgical technique, the bilateral islanded propeller mucoperiosteal flap closure, in managing wide cleft palates while integrating established surgical methods. Design: This study included six pediatric patients with wide cleft palate who underwent surgery using this novel technique, performed by the senior author between 2022 and 2023 at a center in Eastern India. Patients were monitored for two years to evaluate surgical site-related complications and speech outcomes through both subjective and objective assessments. Main Outcome Measure: To determine the reliability of this technique in preventing postoperative fistula formation while promoting optimal speech outcomes. Results: Six pediatric patients underwent corrective surgery for wide cleft palate between the ages of 6 and 12 months. No postoperative complications, such as bleeding, wound dehiscence, hanging palate, or flap necrosis, were observed either immediately after surgery or at the three-week follow-up. At the two-year follow-up, there were no signs of fistula formation at the junction of the hard and soft palate or nasal regurgitation during feeding. Speech function was assessed at regular intervals using classical lateral radiographs at rest and during speech. All patients demonstrated unrestricted soft palate motion with minimal scarring. Conclusion: The Bilateral Islanded Propeller Mucoperiosteal Flap Closure is an innovative and adaptable technique for addressing wide palatal defects. It simplifies surgical management, minimizes scarring, and enhances soft palate length and width. When performed at the appropriate stage, this method effectively preserves speech function.
14 May 2026 in Sultan Qaboos University Medical Journal
Objectives: This study aimed to compare the efficacy of intralesional autologous platelet rich plasma (PRP) injection in post-traumatic and post-surgical scars to a control group managed with silicone-based products. In addition, this study aimed to determine the success rate via aesthetic result, symptom improvement and outcome in terms of complications using autologous PRP on scars caused by burns or trauma. Methods: This randomised controlled trial study was conducted from August 2022 and February 2024 at the Departments of Burns and Plastic Surgery, Surgical Gastroenterology and Obstetrics and Gynaecology, AIIMS, Bhubaneswar, India. Intralesional autologous PRP injections were administered to post-traumatic or post-surgical scars of 6 weeks to 1.5 years duration. The control group was managed with silicone-based products. Clinical outcome of the scars was assessed using the Patient and Observer Scar Assessment Scale (POSAS) to determine improvement in scar characteristics and aesthetics. The Likert scale was also employed to assess the aesthetic satisfaction. Results: A total of 34 patients were included in this study (17 in each group). The PRP group reflected a statistically significant result in terms of both patient and observer factors as a part of the POSAS score. The mean observer POSAS significantly decreased from 16.76 on day 7 to 12.47 at 5 months (P <0.001). Mean patient POSAS also significantly decreased from 26.41 on day 7 to 19.88 at 5 months (P <0.001). Statistically significant improvement in Likert scale in PRP group. Conclusion: Scars following trauma or surgery showcased a significantly more efficient and faster extent of aesthetic and symptomatic improvement when treated with autologous PRP compared to silicone products.
19 August 2026 in Journal of Trauma and Injury